Acinar Cell Adenocarcinomas, Acinic cell tumor, and Acinar cell carcinoma

1		Acelarin First Line Randomised Pancreatic Study	Pancreatic Acinar Carcinoma Pancreatic Neoplasms	Drug: Acelarin Drug: Gemcitabine	Allocation: Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Treatment	Cancer Research UK Liverpool Cancer Trials Unit Liverpool, Merseyside, United Kingdom
2		Selinexor, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Pancreatic Cancer	Acinar Cell Adenocarcinomaof the Pancreas Duct Cell Adenocarcinoma of the Pancreas Stage IV Pancreatic Cancer	Drug: gemcitabine hydrochloride Drug: paclitaxel albumin-stabilized nanoparticle formulation Drug: selinexor (and 2 more...)	Allocation: Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Treatment	Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
3		Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer	Acinar Cell Adenocarcinomaof the Pancreas Duct Cell Adenocarcinoma of the Pancreas Stage III Pancreatic Cancer	Drug: porfimer sodium Procedure: endoscopic ultrasonography Procedure: photodynamic therapy Drug: gemcitabine hydrochloride	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment	IU Simon Cancer Center Indianapolis, Indiana, United States
4		Bortezomib and Carboplatin in Treating Patients With Metastatic Pancreatic Cancer	Acinar Cell Adenocarcinomaof the Pancreas Duct Cell Adenocarcinoma of the Pancreas Stage IV Pancreatic Cancer	Drug: bortezomib Drug: carboplatin Other: laboratory biomarker analysis	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment	MD Anderson Cancer Network Houston, Texas, United States
5		Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy	Pancreatic Acinar Cell Carcinoma Pancreatic Ductal Adenocarcinoma Recurrent Pancreatic Carcinoma Stage IV Pancreatic Cancer	Drug: Akt Inhibitor MK2206 Drug: Fluorouracil Drug: Oxaliplatin Drug: Selumetinib	Allocation: Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Treatment	The University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States The University of Arizona Cancer Center-North Campus Tucson, Arizona, United States University of Arkansas for Medical Sciences Little Rock, Arkansas, United States (and 531 more...)
6		Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer	Pancreatic Acinar Cell Carcinoma Pancreatic Ductal Adenocarcinoma Recurrent Pancreatic Carcinoma Stage IV Pancreatic Cancer	Drug: Carboplatin Other: Laboratory Biomarker Analysis Drug: Paclitaxel Biological: Wild-type Reovirus	Allocation: Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Treatment	MedStar Georgetown University Hospital Washington, District of Columbia, United States Emory University/Winship Cancer Institute Atlanta, Georgia, United States Montefiore Medical Center-Weiler Hospital Bronx, New York, United States (and 3 more...)
7		Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery	Pancreatic Acinar Cell Carcinoma Pancreatic Ductal Adenocarcinoma Stage III Pancreatic Cancer AJCC v6 and v7 Stage IV Pancreatic Cancer AJCC v6 and v7	Biological: Falimarev Biological: Inalimarev Other: Laboratory Biomarker Analysis Biological: Sargramostim	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment	Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
8		Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer	Acinar Cell Adenocarcinomaof the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage I-III Pancreatic Cancer	Drug: metformin hydrochloride Radiation: stereotactic radiosurgery	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment	University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
9		CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer	Acinar Cell Adenocarcinomaof the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage IV Pancreatic Cancer	Drug: 6,8-bis(benzylthio)octanoic acid Drug: oxaliplatin Drug: leucovorin calcium (and 3 more...)	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment	Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States
10		Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery	Acinar Cell Adenocarcinomaof the Pancreas Duct Cell Adenocarcinoma of the Pancreas Stage IIB Pancreatic Cancer Stage III Pancreatic Cancer	Drug: gemcitabine hydrochloride Radiation: hyperfractionated radiation therapy Radiation: intensity-modulated radiation therapy (and 2 more...)	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment	Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
11		Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer	Acinar Cell Adenocarcinomaof the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage IV Pancreatic Cancer	Drug: metformin hydrochloride Drug: oxaliplatin Drug: leucovorin calcium (and 2 more...)	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment	University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
12		Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine	Acinar Cell Adenocarcinomaof the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage IV Pancreatic Cancer	Drug: sunitinib malate	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment	Cancer and Leukemia Group B Chicago, Illinois, United States Memorial Sloan Kettering Cancer Center New York, New York, United States
13		GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery	Adult Solid Neoplasm Pancreatic Acinar Cell Carcinoma Pancreatic Ductal Adenocarcinoma (and 2 more...)	Other: Diagnostic Laboratory Biomarker Analysis Drug: Erlotinib Hydrochloride Drug: Gemcitabine Hydrochloride Drug: Vismodegib	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment	Mayo Clinic in Arizona Scottsdale, Arizona, United States Mayo Clinic in Florida Jacksonville, Florida, United States UF Cancer Center at Orlando Health Orlando, Florida, United States Mayo Clinic Rochester, Minnesota, United States
14		Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer	Acinar Cell Adenocarcinomaof the Pancreas Duct Cell Adenocarcinoma of the Pancreas Stage I Pancreatic Cancer (and 2 more...)	Drug: oxaliplatin Drug: leucovorin calcium Drug: irinotecan hydrochloride (and 3 more...)	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment	Yale University New Haven, Connecticut, United States
15		CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer	Acinar Cell Adenocarcinomaof the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer (and 2 more...)	Drug: 6,8-bis(benzylthio)octanoic acid	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment	Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States
16		Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients With Pancreatic Cancer	Acinar Cell Adenocarcinomaof the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer (and 2 more...)	Drug: oxaliplatin Drug: irinotecan Drug: leucovorin (and 5 more...)	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment	UC San Diego Moores Cancer Center La Jolla, California, United States University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States (and 11 more...)
17		Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery	Acinar Cell Adenocarcinomaof the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer (and 2 more...)	Drug: vismodegib Drug: sirolimus Procedure: positron emission tomography (and 4 more...)	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment	Mayo Clinic Campus in Arizona Scottsdale, Arizona, United States Mayo Clinic Campus in Florida Jacksonville, Florida, United States Mayo Clinic Rochester, Minnesota, United States
18		Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride	Acinar Cell Adenocarcinomaof the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer (and 2 more...)	Drug: sorafenib tosylate Drug: everolimus Other: laboratory biomarker analysis (and 2 more...)	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment	University of Colorado at Denver Health Sciences Center Aurora, Colorado, United States Roswell Park Cancer Institute Buffalo, New York, United States
19		Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas	Acinar Cell Adenocarcinomaof the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer (and 2 more...)	Drug: triapine	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment	Mayo Clinic Rochester, Minnesota, United States
20		Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer	Acinar Cell Adenocarcinomaof the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer (and 2 more...)	Drug: paclitaxel Drug: bryostatin 1	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment	Montefiore Medical Center Bronx, New York, United States
21		Nivolumab and Ipilimumab in Treating Patients With Rare Tumors	Acinar Cell Carcinoma Adenoid Cystic Carcinoma Adrenal Cortex Carcinoma (and 82 more...)	Procedure: Biospecimen Collection Biological: Ipilimumab Biological: Nivolumab	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment	University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States (and 877 more...)
22		Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer	Acinar Cell Adenocarcinomaof the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer (and 3 more...)	Drug: alisertib Drug: gemcitabine	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment	UC Davis Comprehensive Cancer Center Sacramento, California, United States
23		High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery	Acinar Cell Carcinoma Ampulla of Vater Adenocarcinoma Cholangiocarcinoma (and 5 more...)	Procedure: Pancreatectomy Other: Lavage	Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single (Participant) Primary Purpose: Supportive Care	Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States
24		Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery	Pancreatic Acinar Cell Carcinoma Pancreatic Ductal Adenocarcinoma Pancreatic Intraductal Papillary-Mucinous Neoplasm (and 6 more...)	Radiation: 3-Dimensional Conformal Radiation Therapy Drug: Capecitabine Drug: Chemotherapy (and 6 more...)	Allocation: Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Treatment	Providence Hospital Mobile, Alabama, United States Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States Alaska Women's Cancer Care Anchorage, Alaska, United States (and 698 more...)
25		Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung	Acinar Cell Adenocarcinomaof the Pancreas Duct Cell Adenocarcinoma of the Pancreas Liver Metastases (and 5 more...)	Procedure: dynamic contrast-enhanced magnetic resonance imaging Other: pharmacological study Biological: tumor-homing peptide iRGD	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Diagnostic	City of Hope Medical Center Duarte, California, United States
26		Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies	Acinar Cell Adenocarcinomaof the Pancreas Adenocarcinoma of the Gallbladder Adenocarcinoma of Unknown Primary (and 37 more...)	Drug: oxaliplatin Drug: irinotecan hydrochloride Drug: leucovorin calcium (and 2 more...)	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment	University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States Evanston CCOP-NorthShore University HealthSystem Evanston, Illinois, United States
27		Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery	Acinar Cell Adenocarcinomaof the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer (and 5 more...)	Drug: dasatinib Drug: gemcitabine hydrochloride Other: laboratory biomarker analysis (and 3 more...)	Allocation: Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Treatment	Central Hematology Oncology Medical Group, Inc. Alhambra, California, United States TORI FULLERTON (St. Jude Heritage Healthcare Virginia K. Crosson Cancer Center) Fullerton, California, United States Pacific Shores Medical Group Long Beach, California, United States (and 14 more...)
28		Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer	High-grade Salivary Gland Mucoepidermoid Carcinoma Recurrent Salivary Gland Cancer Salivary Gland Acinic Cell Tumor (and 5 more...)	Biological: trastuzumab Other: laboratory biomarker analysis	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment	Southwest Oncology Group San Antonio, Texas, United States
29		Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers	High-grade Salivary Gland Carcinoma High-grade Salivary Gland Mucoepidermoid Carcinoma Low-grade Salivary Gland Carcinoma (and 7 more...)	Drug: lapatinib ditosylate Other: laboratory biomarker analysis	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment	Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada
30		Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer	Pancreatic Cancer	Drug: ifosfamide Drug: mitomycin C	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment	Istituto Scientifico H. San Raffaele Milan, Italy
31		Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer	Pancreatic Cancer	Drug: fluorouracil Drug: gemcitabine hydrochloride Drug: leucovorin calcium Other: clinical observation	Allocation: Randomized Primary Purpose: Treatment	Institute of Oncology at Prince of Wales Hospital Randwick, New South Wales, Australia Flinders Medical Centre Bedford Park, South Australia, Australia Cross Cancer Institute at University of Alberta Edmonton, Alberta, Canada (and 24 more...)
32		Title XELOX FOR SALIVARY GLAND CANCERS	Head and Neck Cancer	Drug: Capecitabine Drug: Oxaliplatin	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment	Dana-Farber Cancer Institute Boston, Massachusetts, United States
33		Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy	Head and Neck Cancer Mucositis Oral Complications of Radiation Therapy Pain	Drug: doxepin hydrochloride Other: placebo	Allocation: Randomized Intervention Model: Crossover Assignment Masking: Double (Participant, Investigator) Primary Purpose: Supportive Care	Mayo Clinic Scottsdale Scottsdale, Arizona, United States Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford, Connecticut, United States Mayo Clinic - Jacksonville Jacksonville, Florida, United States (and 117 more...)
34		MRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck Cancer	Head and Neck Cancer	Procedure: blood-oxygen-level-dependent functional magnetic resonance imaging Procedure: diffusion tensor imaging Procedure: dynamic contrast-enhanced magnetic resonance imaging (and 3 more...)	Observational Model: Case-Only Time Perspective: Prospective	Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
35		Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer	Breast Cancer Colorectal Cancer Head and Neck Cancer (and 2 more...)	Procedure: venipuncture Radiation: radiation therapy	Observational Model: Cohort Time Perspective: Prospective	Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
36		Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer	Head and Neck Cancer	Radiation: stereotactic radiosurgery	Allocation: Non-Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Treatment	Boston University Cancer Research Center Boston, Massachusetts, United States
37		Using Traditional Acupuncture in the Management of Cancer Treatment Related Lymphoedema	Breast Cancer Head and Neck Cancer Lymphedema	Other: Acupuncture and moxibustion	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Supportive Care	Lynda Jackson Macmillan Centre at Mount Vernon Cancer Centre Northwood, United Kingdom
38		PET Scans in Patients With Head And Neck Cancer Who Are Undergoing 3-Dimensional Conformal Radiation Therapy And Intensity-Modulated Radiation Therapy	Head and Neck Cancer	Radiation: 3-dimensional conformal radiation therapy Radiation: fludeoxyglucose F 18 Radiation: intensity-modulated radiation therapy	Allocation: Non-Randomized Masking: None (Open Label) Primary Purpose: Diagnostic	Centre Oscar Lambret Lille, France
39		Head & Neck Cancer Survivorship: Physical and Functional Status	Head and Neck Cancer	Drug: systemic chemotherapy Other: survey administration Procedure: adjuvant therapy (and 4 more...)	Observational Model: Cohort Time Perspective: Prospective	Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
40		Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery	Head and Neck Cancer	Drug: gemcitabine	Allocation: Non-Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Treatment	University of Chicago Cancer Research Center Chicago, Illinois, United States Massachusetts General Hospital Boston, Massachusetts, United States Dana Farber Cancer Institute Boston, Massachusetts, United States (and 3 more...)
41		Family Quality of Life Among Families With a Member Who is a Cancer Patient	Breast Cancer Colorectal Cancer Head and Neck Cancer (and 3 more...)	Other: questionnaire administration Other: survey administration Procedure: quality-of-life assessment	Observational Model: Cohort Time Perspective: Prospective	Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
42		Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain	Cancer	Drug: Fentanyl sublingual spray Drug: Placebo	Intervention Model: Crossover Assignment Masking: Triple (Participant, Investigator, Outcomes Assessor) Primary Purpose: Treatment	InSys Therapeutics, Incorporated Chandler, Arizona, United States
43		Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer	Cancer	Drug: cyclophosphamide Device: Cryoablation	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment	Brady Urological Institute at Johns Hopkins Hospital Baltimore, Maryland, United States
44		Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer	Head and Neck Cancer	Drug: Trastuzumab	Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment	Yale-New Haven Hospital New Haven, Connecticut, United States Hematology/Oncology Associates Port Saint Lucie, Florida, United States Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States (and 7 more...)
45		Cisplatin or Carboplatin Combined With Gemcitabine in Treating Patients With Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor	Head and Neck Cancer	Drug: carboplatin Drug: cisplatin Drug: gemcitabine hydrochloride	Masking: None (Open Label) Primary Purpose: Treatment	CancerCare Manitoba Winnipeg, Manitoba, Canada London Regional Cancer Program at London Health Sciences Centre London, Ontario, Canada Ottawa Hospital Regional Cancer Centre - General Campus Ottawa, Ontario, Canada Princess Margaret Hospital Toronto, Ontario, Canada